A pioneer in research on the treatment of thrombosis

A pioneer in research on the treatment of thrombosis

Dr. Alex C. Spyropoulos is the founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is a Professor of Medicine in North Shore-LIJ Health System and an associate professor of Medicine in the University of Rochester. He is widely recognized for advancing the development of protocols for treatment of thrombosis

Spyropoulos got his B.A. in Biological Basis of Behavior in 1985 from the University of Pennsylvania and completed his M.D. in Medicine in 1992.

In 1993 his completed his Internship at the University of New Mexico and he earned his Diploma in the National Board of Medical Examiners. In 1995 he completed his residency and in 1996 he earned his Diploma in Internal Medicine.

As a disease management consultant on anticoagulation in a managed care setting, Spyropoulos has helped to develop protocols using LMWH (Low Molecular Weight Heparin)   in outpatient-based treatment of venous thromboembolic disease, perioperative “bridging” for patients on chronic anticoagulation, post-operative DVT and medical inpatient prophylaxis and protocols with regards to the use of direct thrombin inhibitors for HIT (Heparin-Ιnduced Τhrombocytopenia).

Dr. Spyropoulos clinical and outcomes research interests include the use of LMWH for treatment of venous thromboembolic disease, the use of alternate anticoagulants in special patient populations such as malignancy and pregnancy, pharmacoeconomic evaluation of outpatient DVT treatment programs, perioperative “bridging” outcomes using anticoagulants, thromboprophylaxis in acutely-ill medical patients and emerging anticoagulants for the treatment of venous thrombosis.

As Clinical Associate Professor of Medicine and Associate Professor of Pharmacy at the University of New Mexico Health Sciences Center, he has developed a clinical thrombosis curriculum as part of the ambulatory medicine rotation.

His articles, letters and editorials have been published in over 50 peer-reviewed journals including Chest, Journal of Thrombosis and Thrombolysis and others.